Given that we and others demonstrated an apoptosis-inducing effect on glioblastoma cells subsequent to Usp9X-silencing [33], we believe that it is worthwhile considering Usp9X as a future therapeutic target. The gene discussed is USP9X; the disease is glioblastoma.